Star Health and Allied Insurance Company Ltd

Quick check

The five things to look at first. Open one for more.

• DebtHigh safetyRated AA by 2 agencies.
• ResultsGrowingIn the Jun 2026 quarter, sales rose 13% and profit rose 26% from a year earlier.
• DilutionNo new sharesNo new shares issued in the last year, so existing shareholders' slices were not cut.
• PromotersSteadyThe promoters (founders or parent) own 58% of the company, about the same as in Jun 2025.
• ValuationCheap vs its pastThe share trades at 29 times its yearly earnings (P/E), cheaper than 96% of the time in the last 4 years. Its usual P/E is about 40.

Star Health and Allied Insurance Company Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

• Valuation (P/E)29 against a typical 33.1: cheaper than most peers (1st = cheapest).2nd of 6
• Sales growth+13.2% against a typical +10.8% from a year earlier.3rd of 6
• Profit growth+25.6% against a typical −7.9% from a year earlier.2nd of 6
• Share price, 3 months−13.2% against a typical −6.7%.5th of 6

Exchange filings and their impact on the company.

• 27 Oct 2026Outcome of Board MeetingHigh impactVery positivePrice −4.9% on 28 Oct
  Q2 profit more than tripled on 19% premium growth and better claims ratio, with Rs 400 crore debt fully repaid.

  Star Health reported Q2 FY27 insurance revenue of Rs 5,074 crore, up 15% year-on-year, and net profit of Rs 265 crore versus Rs 80 crore last year. Gross written premium grew 19.2% to Rs 5,275 crore with claims ratio improving to 69.0% and combined ratio to 92.0%. The company also fully redeemed its Rs 400 crore non-convertible debentures during the quarter, cutting borrowings to Rs 76 crore, and remains well-capitalised with solvency of 2.05 times.

  Full analysisFiling

Results dates and other board meetings. Full calendar

Compounded yearly rates over each period.